Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization

European Journal of Pharmacology

Volumn 316, Issue 2-3, 1996, Pages 195-203

  Delagrange, Philippe ^a   Emerit, M Boris ^c   Merahi, Nacera ^c   Abraham, Christine ^b   Morain, Philippe ^b   Rault, Sylvain ^d   Renard, Pierre ^a   Pfeiffer, Bruno ^a   Guardiola Lemaître, Béatrice ^a   Hamon, Michel ^c  

^a IRIS Institut de Recherches Internationales Servier   (France)

^b INSTITUT DE RECHERCHES SERVIER   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Laboratoire de Parasitologie   (France)

Author keywords

5 HT3 receptor; 5 HT3 receptor agonist; 14C guanidinium; Bezold Jarisch reflex; Emesis; Ferret; Inward current; M1E 115 cells; NG 108 15 cells; Rat

Indexed keywords

1 (3 CHLOROPHENYL)BIGUANIDE; CISPLATIN; ONDANSETRON; PHENYLBIGUANIDE; QUIPAZINE; SEROTONIN; SEROTONIN 3 AGONIST; SEROTONIN 3 RECEPTOR; ZACOPRIDE;

ANESTHESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ELECTROPHYSIOLOGY; FERRET; HEART RATE; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; REFLEX; VOMITING;

ANIMALS; BINDING, COMPETITIVE; CELL MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; ONDANSETRON; PIPERAZINES; PYRAZINES; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 0030571532     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00680-2     Document Type: Article

References (49)

1. 3 receptor antagonist BRL24924 in the inhibition of radiation-evoked emesis in the ferret, Neuropharmacology 26, 1367.
2. 3 receptors in vitro and in vivo, Eur. J. Pharmacol. 237, 299.
3. 3H]granisetron, Biochem. Pharmacol. 45, 2155.
4. 3 receptor recognition sites in the rat entorhinal cortex labelled by structurally diverse radioligands, Br. J. Pharmacol. 105, 500.
5. 3 receptor ligands, Neurosci. Biobehav. Rev. 16, 107.
6. 3 receptor in mammalian NG108-15 cells, J. Physiol. 490, 679.
7. 3 receptors in NG 108-15 neuroblastoma×glioma cells: effect of the novel agonist 1-(m-chlorophenyl)-biguanide, Neuropharmacology 31, 561.
8. 14C]-guanidinium, Br. J. Pharmacol. 108, 436.
9. Bradford, M.M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72, 248.
10. 3 receptors, Br. J. Pharmacol. 94, 397.
11. 3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride, J. Pharmacol. Exp. Ther. 248, 197.
12. 3 receptors are membrane ion channels, Nature, 339, 706.
13. 3 receptor ligands and substance P, J. Neurochem. 60, 2059.
14. Fozard, J.R., 1984a, Neuronal 5-HT receptors in the periphery, Neuropharmacology 23, 1473.
15. Fozard, J.R., 1984b, MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptorsn, Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 36.
16. 3 receptors mediate cisplatin-induced emesis in dogs, Jpn. J. Pharmacol. 59, 221.
17. Fukui, H., M. Yamamoto, T. Ando, S. Sasaki and S. Sato, 1993, Increase in serotonin levels in the dog ileum and blood by cisplatin as measured by microdialysis, Neuropharmacology 32, 959.
18. 4 receptors in guinea-pig and rat brain, Br. J. Pharmacol. 10, 618.
19. Hamill, O.P., A. Marty, E. Neher, B. Sakmann and J. Sigworth, 1981, Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches, Pflügers Arch. 391, 85.
20. 3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding, Mol. Pharmacol. 33, 303.
21. 3H]-ketanserin, Eur. J. Pharmacol. 118, 13.
22. Ireland, S.J. and M.B. Tyers, 1987, Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve, Br. J. Pharmacol. 90, 229.
23. Kamato, T., H. Ito, Y. Nagakura, A. Nishida, H. Yuki, M. Yamano and K. Miyata, 1993, Mechanisms of cisplatin- and m-chlorophenylbiguanide-induced emesis in ferret, Eur. J. Pharmacol. 238, 369.
24. 3 receptors in vitro and in vivo, Third IUPHAR sat. Meet. Serotonin, Chicago, Aug. 1994, Abstr. 53, p. 82.
25. 3 receptor agonist, Eur. J. Pharmacol. 182, 193.
26. 3 receptors, Med. Res. Rev. 10,441.
27. 3 receptors, ed. M. Hamon (Academic Press, London) p. 33.
28. Léna, C. and J.P. Changeux, 1993, Allosteric modulations of the nicotinic acetylcholine receptor, Trends Neurosci. 16 (suppl.), 181.
29. 3 recognition sites on vagal afferent terminals in the brainstem of the ferret, Neuroscience 38, 667.
30. 3H-ligand for serotonin 2 receptor binding sites; binding properties, brain distribution and functional role, Mol. Pharmacol. 21, 301.
31. Miller, A.D. and S. Nonaka, 1992, Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: Effect of vagotomy, splanchnicectomy or area postrema lesion, J. Pharmacol. Exp. Ther. 260, 509.
32. 3 binding sites solubilized from membranes of NG 108-15 neuroblastoma-glioma cells, J. Neurochem. 55, 1526.
33. Morain, P., C. Abraham, B. Portevin and G. De Nanteuil, 1994, Biguanide derivatives: agonist pharmacology at 5-hydroxytryptamine type 3 receptors in vitro, Mol. Pharmacol. 46, 732.
34. 1C binding sites in rat frontal cortex, J. Neurochem. 47, 529.
35. 3 receptor agonist, in rodents, J. Neural Transm. (Gen. Sect.) 102, 83.
36. 3 receptors, Part 1: Synthesis and Biological Evaluation of Piperazino Pyrrolothienopyrazines (PPTP), J. Med. Chem. 39, 2068.
37. Richardson, B.P., G. Engel, P. Donatsch and P.A. Stadler, 1985, Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs, Nature 316, 126.
38. Round, A. and D.I. Wallis, 1987, Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists, Neuropharmacology 26, 39.
39. Sancilio, L.F., L.M. Pinkus, C.B. Jackson and H.R. Munson, Jr., 1991, Studies on the emetic and antiemetic properties of zacopride and its enantiomers, Eur. J. Pharmacol. 192, 365.
40. 1C receptors in choroid plexus, J. Pharmacol. Exp. Ther. 247, 169.
41. 3 receptor antagonism by BRL 43694 (granisetron), Eur. J. Pharmacol. 159, 113.
42. 3 receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 344, 143.
43. 3 receptors in N1E-115 neuroblastoma cells, Br. J. Pharmacol. 104: 536.
44. 3 antagonist, J. Pharm. Pharmacol. 40, 301.
45. 3H]ICS 205-930, Neuroscience 31, 393.
46. 1D receptor: A progress review, Neurochem. Res. 15, 567.
47. Wallis, D.I., 1989, Interaction of 5-hydroxytryptamine with autonomic and sensory neurones, in: The peripheral actions of 5-hydroxytryptamine, ed. J.R. Fozard (Oxford University Press, Oxford) p. 220.
48. 3 receptor in a rat glioma × mouse neuroblastoma hybrid cell, J. Physiol. 436, 293.
49. Zifa, E. and G. Fillion, 1992, 5-Hydroxytryptamine receptors, Pharmacol. Rev. 44, 401.